论文部分内容阅读
目的:探讨阿罗格脱敏液脱敏治疗变应性鼻炎患者的安全性。方法:采用阿罗格脱敏试剂对256例变应性鼻炎患进行12580次脱敏治疗,根据点刺试验情况,选择相应敏感的典型过敏原进行脱敏。观察并记录分析其脱敏治疗期间局部及全身反应发生情况。结果:发生局部反应84例,共560例次,总发生百分率为4.45%(560/12580);全身反应发生21例,共39例次,总发生百分率为0.31%(39/12580);局部及全身反应均较轻。结论:阿罗格脱敏治疗是一种安全可行的治疗方法,但适合于国人及个体的脱敏方案仍需在实践中进一步进行完善。
Objective: To investigate the safety of Arroge desensitization liquid in patients with allergic rhinitis. Methods: Altroge desensitization reagent was used to desensitize 12580 patients with allergic rhinitis in 256 cases. According to the prick test, the corresponding sensitive allergens were selected for desensitization. Observe and record the desensitization treatment during the local and systemic reactions. Results: A total of 560 cases occurred in 560 cases with a total incidence of 4.45% (560/12580). There were 21 cases of systemic reactions (39 cases) with a total incidence of 0.31% (39/12580) Systemic reactions are lighter. Conclusion: Arroge desensitization is a safe and feasible treatment, but the desensitization protocol suitable for both individuals and individuals still needs to be further improved in practice.